Exelixis, Inc. (0IJO.L)
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
$53.43-0.04%
StockGlow Score
Bullish
BearishBullish
1 year ago+41.5%
The outlook
Exelixis, Inc. currently reads as bullish based on above its 50- & 200-day averages, 92% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Market cap
—
52-wk high
$56.50
52-wk low
$17.42
50-day avg
$21.98
200-day avg
$21.24
Trailing P/E
0.6